MyFinsight
Home
Compare
About
Recent SEC Filings
10/9
MICRON TECHNOLOGY INC
(MU)
10/9
DELTA AIR LINES, INC.
(DAL)
10/8
PEPSICO INC
(PEP)
10/8
LEVI STRAUSS & CO
(LEVI)
10/8
CONSTELLATION BRANDS, INC.
(STZ)
10/8
CINTAS CORP
(CTAS)
10/6
Lamb Weston Holdings, Inc.
(LW)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/9
MICRON TECHNOLOGY INC
(MU)
10/9
DELTA AIR LINES, INC.
(DAL)
10/8
PEPSICO INC
(PEP)
10/8
LEVI STRAUSS & CO
(LEVI)
10/8
CONSTELLATION BRANDS, INC.
(STZ)
10/8
CINTAS CORP
(CTAS)
10/6
Lamb Weston Holdings, Inc.
(LW)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Lakewood-Amedex Biotherapeutics Inc. (LABT)
Lakewood-Amedex Biotherapeutics Inc. (LABT)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Change in Cash
$2,573,065
Unit: Dollar
Positive Cash Flow Breakdown
Net proceeds from issuance of se...
Issuance of common stock for pro...
Stock-based compensation
Others
Negative Cash Flow Breakdown
Purchases of investments
Accounts payable
Accrued expenses and other curre...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
Net loss
-3,772,008
-923,291
Depreciation
1,158
1,159
Stock-based compensation
61,245
46,180
Amortization of right-of-use asset
29,538
29,333
Issuance of common stock for professional services
2,434,080
-
Prepaid expenses and other assets
221,297
-30,072
Accounts payable
-381,887
166,788
Accrued expenses and other current liabilities
-233,358
290,851
Accrued interest related parties
8,219
38,219
Operating lease liability
-29,720
-29,002
Net cash used in operating activities
-2,104,030
-349,691
Purchases of investments
2,000,000
-
Net cash used in investing activities
-2,000,000
-
Net proceeds from issuance of series c convertible preferred stock
6,802,095
-
Proceeds from notes payable - related parties
43,158
125,000
Proceeds from notes payable other
30,000
-
Repayment of notes payable - related parties
168,158
-
Repayment of notes payable - other
30,000
-
Net cash provided by financing activities
6,677,095
125,000
Net increase in cash and cash equivalents
2,573,065
-224,691
Cash and cash equivalents - beginning of period
11,709
236,400
Cash and cash equivalents - end of period
2,584,774
11,709
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
LABT Cash Flow Sankey Diagram
Sankey diagram visualizing LABT cash flow for the period
Net proceeds from
issuance of series c...
$6,802,095
Proceeds from notes
payable - related...
$43,158
Proceeds from notes
payable other
$30,000
Net cash provided by
financing activities
$6,677,095
Canceled cashflow
$198,158
Net increase in cash
and cash...
$2,573,065
Canceled cashflow
$4,104,030
Repayment of notes payable
- related parties
$168,158
Repayment of notes payable
- other
$30,000
Issuance of common stock
for professional...
$2,434,080
Stock-based compensation
$61,245
Amortization of right-of-use
asset
$29,538
Accrued interest
related parties
$8,219
Depreciation
$1,158
Net cash used in
operating activities
-$2,104,030
Net cash used in
investing activities
-$2,000,000
Canceled cashflow
$2,534,240
Net loss
-$3,772,008
Purchases of investments
$2,000,000
Accounts payable
-$381,887
Accrued expenses and
other current...
-$233,358
Prepaid expenses and
other assets
$221,297
Operating lease liability
-$29,720
Buy us a coffee